Patient preferences for active ulcerative colitis treatments and fecal microbiota transplantation
Background: Fecal microbiota transplantation (FMT) is a promising treatment for active ulcerative colitis (UC). Understanding patient preferences can identify treatment features that may impact treatment decisions, improve shared decision-making, and contribute to patient-centered care, which is esp...
Saved in:
Main Authors: | Deborah A. Marshall (Author), Karen V. MacDonald (Author), Dina Kao (Author), Charles N. Bernstein (Author), Gilaad G. Kaplan (Author), Humberto Jijon (Author), Glen Hazlewood (Author), Remo Panaccione (Author), Yasmin Nasser (Author), Maitreyi Raman (Author), Paul Moayyedi (Author) |
---|---|
Format: | Book |
Published: |
SAGE Publishing,
2024-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Ischemic colitis complicated by infection treated with fecal microbiota transplantation
by: Seok Hyung Kang, et al.
Published: (2023) -
Ulcerative Colitis: Shifting Sands
by: Geert R. A. M. D'Haens, et al.
Published: (2019) -
Fecal Microbiota Transplantation: Is It Safe?
by: Seon-Young Park, et al.
Published: (2021) -
Core Altered Microorganisms in Colitis Mouse Model: A Comprehensive Time-Point and Fecal Microbiota Transplantation Analysis
by: Lijun Shang, et al.
Published: (2021) -
Fecal Microbiota Transplantation and the Brain Microbiota in Neurological Diseases
by: Marco Ruggiero
Published: (2016)